SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences India informs about board meeting

07 Feb 2020 Evaluate

SMS Lifesciences India has informed that the meeting of the Board of Directors of the Company has been scheduled on Friday, February 14, 2020, to consider and approve, the Unaudited Financial Results for the 3rd quarter and nine months ended December 31, 2019. In view of the SEBI (PIT) Regulations, 2015 as amended and in continuation to its letter dated December 31,2019 with respect to closure of trading window of the Company, the Trading Window for dealing in the shares of the Company by the insiders has been closed from January 1, 2020 to February 16, 2020.

The above information is a part of company's filings submitted to BSE.

Haleos Labs Share Price

1356.00 5.40 (0.40%)
12-Jun-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.70
Dr. Reddys Lab 1267.00
Cipla 1385.90
Zydus Lifesciences 1103.00
Lupin 2289.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: